Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma
Supplementary Data
Supplementary Data
Files in this Data Supplement:
Supplementary Figure 5
- pdf file
Supplementary Data
- Doc file
Supplementary Figures_and_Tables
- doc file